These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33646611)

  • 1. Implementing an integrated multi-technology platform for drug checking: Social, scientific, and technological considerations.
    Wallace B; Hills R; Rothwell J; Kumar D; Garber I; van Roode T; Larnder A; Pagan F; Aasen J; Weatherston J; Gozdzialski L; Ramsay M; Burek P; Azam MS; Pauly B; Storey MA; Hore D
    Drug Test Anal; 2021 Apr; 13(4):734-746. PubMed ID: 33646611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
    Gozdzialski L; Wallace B; Hore D
    Harm Reduct J; 2023 Mar; 20(1):39. PubMed ID: 36966319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW; Gill CG
    J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative assessment of key considerations for drug checking service implementation.
    Grace Rose C; Pickard AS; Kulbokas V; Hoferka S; Friedman K; Epstein J; Lee TA
    Harm Reduct J; 2023 Oct; 20(1):151. PubMed ID: 37848875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of North American drug checking services operating in 2022.
    Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC
    Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
    Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
    Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies.
    Bhuiyan I; Tobias S; Ti L
    Am J Drug Alcohol Abuse; 2023 Nov; 49(6):685-690. PubMed ID: 37506334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
    Carroll JJ; Mackin S; Schmidt C; McKenzie M; Green TC
    Harm Reduct J; 2022 Feb; 19(1):9. PubMed ID: 35120531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications.
    Sisco E; Nestadt DF; Bloom MB; Schneider KE; Elkasabany RA; Rouhani S; Sherman SG
    Drug Test Anal; 2024 Sep; 16(9):942-947. PubMed ID: 38043944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
    Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA.
    Karch L; Tobias S; Schmidt C; Doe-Simkins M; Carter N; Salisbury-Afshar E; Carlberg-Racich S
    Drug Alcohol Depend; 2021 Nov; 228():108976. PubMed ID: 34536717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B; van Roode T; Burek P; Hore D; Pauly B
    Harm Reduct J; 2022 Dec; 19(1):143. PubMed ID: 36539747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C; Matsumoto A; Boulad M; Stopka TJ
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.